Gliomatosis cerebri secondary prevention: Difference between revisions

	Gliomatosis cerebri Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gliomatosis cerebri from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gliomatosis cerebri secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gliomatosis cerebri secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gliomatosis cerebri secondary prevention
CDC on Gliomatosis cerebri secondary prevention
Gliomatosis cerebri secondary prevention in the news
Blogs on Gliomatosis cerebri secondary prevention
Directions to Hospitals Treating Gliomatosis cerebri
Risk calculators and risk factors for Gliomatosis cerebri secondary prevention

Revision as of 19:19, 5 October 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

@@ Line 6: / Line 6: @@
 ==Secondary Prevention==
-* For the risk factors are not clear, the preventive measure is unknown.
 ==References==